Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) announced its participation in the World Trade Center (WTC) Utah trade mission to South Korea and Japan from September 24-October 5, 2024. The company will join Utah Governor Cox and the Governor's Office of Economic Opportunity delegation for life sciences and innovation. This mission aims to expand Co-Dx's international relationships as it prepares to introduce a new PCR diagnostic platform for at-home and point-of-care use.
Co-Diagnostics has a history of international ventures, including a joint venture in India established in 2017 and a network of distributors, partners, and customers in over 50 countries. The company's CEO, Dwight Egan, emphasized the importance of building global relationships to improve access to care and increase the availability of high-quality PCR diagnostics worldwide.
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) ha annunciato la sua partecipazione alla missione commerciale del World Trade Center (WTC) Utah in Corea del Sud e Giappone dal 24 settembre al 5 ottobre 2024. L'azienda parteciperà con il Governatore dell'Utah Cox e la delegazione dell'Ufficio delle Opportunità Economiche del Governatore per le scienze della vita e l'innovazione. Questa missione punta a espandere le relazioni internazionali di Co-Dx in preparazione per l'introduzione di una nuova piattaforma diagnostica PCR per uso domestico e presso i punti di cura.
Co-Diagnostics ha una storia di iniziative internazionali, inclusa una joint venture in India istituita nel 2017 e una rete di distributori, partner e clienti in oltre 50 paesi. Il CEO dell'azienda, Dwight Egan, ha sottolineato l'importanza di costruire relazioni globali per migliorare l'accesso alle cure e aumentare la disponibilità di diagnosi PCR di alta qualità in tutto il mondo.
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) anunció su participación en la misión comercial del World Trade Center (WTC) Utah a Corea del Sur y Japón del 24 de septiembre al 5 de octubre de 2024. La empresa se unirá al Gobernador de Utah, Cox, y a la delegación de la Oficina de Oportunidades Económicas del Gobernador para las ciencias de la vida y la innovación. Esta misión tiene como objetivo expandir las relaciones internacionales de Co-Dx mientras se prepara para introducir una nueva plataforma de diagnóstico PCR para uso en casa y en puntos de atención.
Co-Diagnostics tiene una historia de iniciativas internacionales, incluida una empresa conjunta en India establecida en 2017, así como una red de distribuidores, socios y clientes en más de 50 países. El CEO de la empresa, Dwight Egan, enfatizó la importancia de construir relaciones globales para mejorar el acceso a la atención y aumentar la disponibilidad de diagnósticos PCR de alta calidad en todo el mundo.
Co-Diagnostics, Inc. (Nasdaq-CM: CODX)는 2024년 9월 24일부터 10월 5일까지 한국과 일본을 위한 유타 세계 무역 센터(WTC) 상업 미션에 참여한다고 발표했습니다. 회사는 유타 주지사 콕스 및 생명과학과 혁신을 위한 주지사 경제 기회 사무소의 델리게이션과 함께할 것입니다. 이 미션은 Co-Dx가 가정용 및 진료소에서 사용할 수 있는 새로운 PCR 진단 플랫폼을 도입할 준비를 하면서 국제 관계를 확장하는 것을 목표로 합니다.
Co-Diagnostics는 2017년에 설립된 인도에서의 합작 투자 및 50개 이상의 국가에 있는 유통업체, 파트너 및 고객의 네트워크를 포함하여 국제적 비즈니스의 역사를 가지고 있습니다. 회사의 CEO인 드와이트 이건(Dwight Egan)은 치료 접근성을 향상시키고 전 세계적으로 고품질 PCR 진단의 가용성을 증가시키기 위해 글로벌 관계를 구축하는 것의 중요성을 강조했습니다.
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) a annoncé sa participation à la mission commerciale du World Trade Center (WTC) Utah en Corée du Sud et au Japon du 24 septembre au 5 octobre 2024. L'entreprise rejoindra le gouverneur de l'Utah, Cox, et la délégation du Bureau des opportunités économiques du gouverneur pour les sciences de la vie et l'innovation. Cette mission vise à étendre les relations internationales de Co-Dx alors qu'elle se prépare à introduire une nouvelle plateforme de diagnostic PCR pour une utilisation à domicile et au point de soins.
Co-Diagnostics a une histoire d'initiatives internationales, y compris une coentreprise en Inde établie en 2017 et un réseau de distributeurs, partenaires et clients dans plus de 50 pays. Le PDG de l'entreprise, Dwight Egan, a souligné l'importance de construire des relations mondiales pour améliorer l'accès aux soins et augmenter la disponibilité de diagnostics PCR de haute qualité dans le monde entier.
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) hat seine Teilnahme an der Handelsmission des World Trade Center (WTC) Utah nach Südkorea und Japan vom 24. September bis 5. Oktober 2024 angekündigt. Das Unternehmen wird gemeinsam mit dem Gouverneur von Utah, Cox, und der Delegation des Büros für wirtschaftliche Chancen des Gouverneurs für Lebenswissenschaften und Innovation teilnehmen. Diese Mission zielt darauf ab, die internationalen Beziehungen von Co-Dx auszubauen, während es sich auf die Einführung einer neuen PCR-Diagnoseplattform für den Einsatz zu Hause und an Behandlungsstellen vorbereitet.
Co-Diagnostics hat eine Geschichte internationaler Unternehmungen, darunter ein 2017 gegründetes Joint Venture in Indien und ein Netzwerk von Distributoren, Partnern und Kunden in über 50 Ländern. Der CEO des Unternehmens, Dwight Egan, betonte die Bedeutung des Aufbaus globaler Beziehungen, um die Zugang zu Gesundheitsversorgung zu verbessern und die Verfügbarkeit hochwertiger PCR-Diagnosetests weltweit zu erhöhen.
- Participation in a prestigious trade mission to South Korea and Japan
- Preparation for introducing a new PCR diagnostic platform for at-home and point-of-care use
- Existing international presence with distributors, partners, and customers in over 50 countries
- None.
Co-Dx will join the delegation for life sciences and innovation, aiming to expand its international relationships. The company announced the creation of a joint venture in
The itinerary for the trip includes visits with industry leaders in a region of the world that the Company anticipates playing a role in its future.
"Building a global network of relationships is vital as we advance our mission of improving access to care for patients around the world, increasing the availability and accessibility of high-quality PCR diagnostics," said Dwight Egan, Chief Executive Officer, Co-Diagnostics, Inc. "We are pleased to be part of this prestigious trade mission and to help further
World Trade Center Utah is the official international business promotion organization for the Governor's Office of Economic Opportunity in the
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Forward-looking statements in this release include statements regarding our preparation for introducing a new PCR diagnostic platform designed for at-home and point-of-care use and our efforts to advance our mission of improving access to care for patients around the world and increasing the availability and accessibility of high-quality PCR diagnostics. Actual results may differ materially from those contemplated or anticipated by such forward-looking statements. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in our Risk Factors disclosure in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 14, 2024, and in our other filings with the SEC. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-accompany-utah-governor-and-wtc-utah-on-trade-mission-to-south-korea-and-japan-302256743.html
SOURCE Co-Diagnostics
FAQ
When is Co-Diagnostics (CODX) participating in the trade mission to South Korea and Japan?
What is the purpose of Co-Diagnostics (CODX) joining the Utah trade mission?
How many countries does Co-Diagnostics (CODX) have distributors, partners, and customers in?
What new product is Co-Diagnostics (CODX) preparing to introduce?
